If Approved, Next Hurdle Would Be Reimbursement
Subcutaneous injection of a weight loss drug. getty Eli Lilly’s weight loss drug, tirzepatide, showed substantial potential in a large Phase 3 study, the results of which were reported on…
Subcutaneous injection of a weight loss drug. getty Eli Lilly’s weight loss drug, tirzepatide, showed substantial potential in a large Phase 3 study, the results of which were reported on…